Prelude Therapeutics Inc (PRLD) Stock News

PRLD Stock News & Headlines

Latest stock news and headlines for Prelude Therapeutics Inc (PRLD). Stay informed on earnings reports, analyst upgrades and downgrades, market-moving events, and company announcements.

Current stock price: $4.74. Market cap: $297.98M. Sector: Healthcare. Industry: Biotechnology. This page aggregates the latest news articles relevant to PRLD from financial news sources, helping investors stay current on events that may impact Prelude Therapeutics Inc's stock price.

News catalysts can drive significant short-term price movement. Earnings surprises, management changes, product launches, regulatory decisions, and analyst coverage changes all create opportunities and risks. Combine news monitoring with GoodMoat's fundamental analysis, quality scores, and valuation tools for a complete research workflow on Prelude Therapeutics Inc (PRLD).